Characterization of antibodies directed against the immunoglobulin light κ chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 152-160

  De Re, Valli ^b   Simula, Maria Paola ^a   Pavan, Alessandro ^a   Garziera, Marica ^a   Marin, Dolores ^a   Dolcetti, Riccardo ^b   De Vita, Salvatore ^c   Sansonno, Domenico ^d   Geremia, Silvano ^e   Toffoli, Giuseppe ^a  

^a Dipartimento di Oncologia Molecolare e Ricerca Traslazionale   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF TRIESTE   (Italy)

Author keywords

HCV; Idiotype; Lymphoma; Monoclonal antibody; NHL; Single chain immunoglobulin variable fragment; Type II mixed cryoglobulinemia

Indexed keywords

EPITOPE; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN IDIOTYPE; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 213; MONOCLONAL ANTIBODY 215; MONOCLONAL ANTIBODY 216; MONOCLONAL ANTIBODY 319; MONOCLONAL ANTIBODY 338; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; B LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; CRYOGLOBULINEMIA; CYTOFLUOROMETRY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGLOBULIN VARIABLE REGION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; WESTERN BLOTTING;

HEPATITIS C VIRUS;

EID: 69949136109     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04677.x     Document Type: Conference Paper

References (22)

1. De Re, V. et al. 2008. Mixed cryoglobulinemia syndrome as an additional autoimmune disorder associated with risk for lymphoma development. Blood 111: 5760.
2. Ferri C. et al. 2007. B-cells and mixed cryoglobuline-mia. Autoimmun. Rev. 7: 114-120.
3. Landau, D.A. et al. 2007. The pathophysiology of HCV induced B-cell clonal disorders. Autoimmun. Rev. 6: 581-587.
4. Ramos-Casals, M. et al. 2005. Hepatitis C virus, Sjo-gren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun. Rev. 4: 8-15.
5. De Re, V. et al. 2007. B-cell lymphomas associated with HCV infection. Gastroenterology 132: 1205-1207.
6. De Cerio, A.L. et al. 2007. Anti-idiotype antibodies in cancer treatment. Oncogene 26: 3594-3602.
7. Miller, R.A. et al. 1982. Treatment of B-cell lym-phoma with monoclonal anti-idiotype antibody. N. Engl. J. Med. 306: 517-522.
8. De Re, V. et al. 2002. Salivary gland B cell lympho-proliferative disorders in Sjogren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas. Eur. J. Immunol. 32: 903-910.
9. Perotti M. et al. 2008. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia. Autoim-mun. Rev. 7: 468-472.
10. Charles E.D. et al. 2007. Clonal expansion of IgM+CD27+B cells in HCV-associated mixed cryo-globulinemia. Blood 111: 1344-1356.
11. De Re, V. et al. 2000. Sequence analysis of the im-munoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 96: 3578-3584.
12. De Re, V. et al. 2006. HCV-NS3 and IgG-Fc crossre-active IgM in patients with type II mixed cryoglobu-linemia and B-cell clonal proliferations. Leukemia 20: 1145-1154.
13. Ferraccioli, G. & B. Tolusso. 2007. Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different im-munological settings. Autoimmun. Rev. 7: 109-113.
14. De Re, V. et al. 2000. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int. J Cancer 87: 211-216.
15. De Re, V. et al. 2002. Salivary gland B cell lympho-proliferative disorders in Sjogren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas. Eur. J. Immunol.
16. Roulland, S. et al. 2008. Pathophysiological aspects of memory B-cell development. Trends Immunol. 29: 25-33.
17. Gricks, C.S. & J.G. Gribben. 2003. Cytotoxic T cell responses against immunoglobulin in malignant and normal B cells: implications for tumor immunity and autoimmunity. Curr. Pharm. Des. 9: 1889-1903.
18. Bomben, R. et.al. 2008. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multi-centre study. Br. J. Haematol. Epub ahead of print.
19. Hadzidimitriou, A. et al. 2008. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukaemia. Blood Epub ahead of print.
20. Messmer, B.T. et al. 2004. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J. Exp. Med. 200: 519-525.
21. Bende, J. et al. 2005. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201: 1229-1241.
22. Marasca, R. et.al. 2001. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lym-phoma. Am. J. Pathol. 159: 253-261.